Breaking News Instant updates and real-time market news.

ALXN

Alexion

$146.46

2.39 (1.66%)

18:01
09/13/17
09/13
18:01
09/13/17
18:01

Alexion: Soliris study results show sustained treatment benefits

Alexion Pharmaceuticals announced results from an interim analysis of an ongoing Phase 3 open-label extension study of the pivotal, placebo-controlled REGAIN study of Soliris for the treatment of patients with refractory generalized myasthenia gravis who are anti-acetylcholine receptor antibody-positive. The new results show sustained treatment benefits across a range of MG-specific assessment scales through an additional 52 weeks for patients who continued to receive Soliris, and also demonstrate rapid, significant and sustained improvements through 52 weeks for patients who had crossed over from placebo in REGAIN to Soliris treatment in the extension study. The safety profile of Soliris was consistent with that observed in the REGAIN study. "There is an urgent need for a treatment for patients with refractory gMG who have attempted multiple therapies and continue to suffer from severe symptoms and complications," said Professor James F. Howard, MD, Department of Neurology at the University of North Carolina, Chapel Hill, USA, and lead investigator in REGAIN and its open-label extension study. "These new results build on the findings of the REGAIN study, and it is encouraging to see the rapid and sustained benefits of Soliris treatment with patients recovering functional ability to carry out activities of daily living, and quality of life."

  • 27

    Sep

  • 23

    Oct

ALXN Alexion
$146.46

2.39 (1.66%)

08/16/17
EVER
08/16/17
INITIATION
Target $137
EVER
In Line
Alexion initiated with an In Line at Evercore ISI
Evercore ISI analyst Josh Schimmer initiated Alexion with an In Line and a $137 price target.
09/05/17
JPMS
09/05/17
UPGRADE
Target $175
JPMS
Overweight
Alexion upgraded to Overweight from Neutral at JPMorgan
JPMorgan analyst Anupam Rama upgraded Alexion Pharmaceuticals to Overweight and raised his price target for the shares to $175 from $163. The stock closed Friday up $1.67 to $144.08. Alexion set low expectations for second half of 2017 earnings and the Street is now shifting its focus to clinical catalysts over the next 6-12 months, Rama tells investors in a research note. The analyst has a positive stance on a supplemental approval of Soliris for myasthenia gravis by the October FDA action date as well as continued confidence in ALXN1210 as a "long-term defense point for Alexion's complement franchise."
09/07/17
LEER
09/07/17
NO CHANGE
LEER
Alexion, Celgene top picks at Leerink
Leerink analyst Geoffrey Porges notes large cap biotech stocks have performed strongly this year and have reversed some of the wide discount they were carrying compared to their history and to other medical products sectors. Further, he points out consensus revenue and earnings estimates for biotech companies have started to trend positively, after negative revisions earlier in the year. Porges still sees significant upside for many of the names in his coverage, and he anticipates that further appreciation can occur on the basis of recovering sentiment and multiples, further estimate revisions toward his current models, and confirmation of option value for unpriced pipeline opportunities. The analyst top picks are now Alexion (ALXN), Celgene (CELG), Regeneron (REGN), and Vertex (VRTX). Among his Market Perform rated stocks, his preference would be for AbbVie (ABBV).
09/13/17
LEER
09/13/17
NO CHANGE
Target $182
LEER
Outperform
Alexion price target raised to $182 from $170 at Leerink
Leerink analyst Geoffrey Porges raised his price target for Alexion to $182 from $170 on valuation. The analyst reiterates an Outperform rating on the shares.

TODAY'S FREE FLY STORIES

TWX

Time Warner

$87.71

-1.01 (-1.14%)

, T

AT&T

$34.64

0.13 (0.38%)

05:02
11/21/17
11/21
05:02
11/21/17
05:02
Recommendations
Time Warner, AT&T analyst commentary  »

Time Warner price target…

TWX

Time Warner

$87.71

-1.01 (-1.14%)

T

AT&T

$34.64

0.13 (0.38%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Nov

MRVL

Marvell

$21.59

1.3 (6.41%)

, CAVM

Cavium

$84.02

8.19 (10.80%)

04:56
11/21/17
11/21
04:56
11/21/17
04:56
Upgrade
Marvell, Cavium rating change  »

Marvell upgraded to…

MRVL

Marvell

$21.59

1.3 (6.41%)

CAVM

Cavium

$84.02

8.19 (10.80%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

  • 28

    Nov

  • 28

    Nov

PAAS

Pan American Silver

$14.98

-0.22 (-1.45%)

04:55
11/21/17
11/21
04:55
11/21/17
04:55
Conference/Events
Pan American Silver investor and analyst day »

Investor and Analyst Day…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

  • 28

    Nov

  • 05

    Dec

FMS

Fresenius Medical

$48.59

-0.24 (-0.49%)

04:55
11/21/17
11/21
04:55
11/21/17
04:55
Conference/Events
Fresenius Medical participates in a conference call with JPMorgan »

JPMorgan European MedTech…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CCMP

Cabot Microelectronics

$99.75

1.33 (1.35%)

04:55
11/21/17
11/21
04:55
11/21/17
04:55
Conference/Events
Cabot Microelectronics management to meet with Loop Capital »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

  • 28

    Nov

  • 29

    Nov

  • 04

    Jan

HCKT

Hackett Group

$16.13

0.14 (0.88%)

04:55
11/21/17
11/21
04:55
11/21/17
04:55
Conference/Events
Hackett Group management to meet with Roth Capital »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

TSLA

Tesla

$308.74

-6.31 (-2.00%)

04:55
11/21/17
11/21
04:55
11/21/17
04:55
Conference/Events
Tesla management to meet with Evercore ISI »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

  • 16

    Jan

EXAS

Exact Sciences

$58.86

-0.01 (-0.02%)

04:55
11/21/17
11/21
04:55
11/21/17
04:55
Conference/Events
Exact Sciences management to meet with Benchmark »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

  • 30

    Nov

04:55
11/21/17
11/21
04:55
11/21/17
04:55
Conference/Events
Macquarie to hold a conference »

Internet, Media &…

BBY

Best Buy

$56.35

0.52 (0.93%)

04:55
11/21/17
11/21
04:55
11/21/17
04:55
Conference/Events
Best Buy management to meet with Jefferies »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

AUPH

Aurinia Pharmaceuticals

$5.13

-0.01 (-0.19%)

04:55
11/21/17
11/21
04:55
11/21/17
04:55
Conference/Events
Aurinia Pharmaceuticals management to meet with Seaport Global »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

04:55
11/21/17
11/21
04:55
11/21/17
04:55
General news
Breaking General news story  »

Federal Reserve Chair…

04:55
11/21/17
11/21
04:55
11/21/17
04:55
General news
Breaking General news story  »

4-Week Bill Auction to be…

MCS

Marcus

04:55
11/21/17
11/21
04:55
11/21/17
04:55
Conference/Events
Marcus management to meet with Benchmark »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

  • 04

    Dec

AVA

Avista

$51.83

-0.09 (-0.17%)

04:55
11/21/17
11/21
04:55
11/21/17
04:55
Conference/Events
Avista to host special shareholder meeting »

Special Shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

04:55
11/21/17
11/21
04:55
11/21/17
04:55
General news
Breaking General news story  »

Week of 11/18 Redbook to…

BIOS

BioScrip

$2.20

-0.02 (-0.90%)

04:55
11/21/17
11/21
04:55
11/21/17
04:55
Conference/Events
BioScrip management to meet with Stephens »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

  • 06

    Dec

AEL

American Equity

$29.68

0.06 (0.20%)

04:55
11/21/17
11/21
04:55
11/21/17
04:55
Conference/Events
American Equity management to meet with Sandler O'Neill »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

WPG

Washington Prime

$7.28

-0.06 (-0.82%)

04:55
11/21/17
11/21
04:55
11/21/17
04:55
Conference/Events
Washington Prime management to meet with Oppenheimer »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

04:55
11/21/17
11/21
04:55
11/21/17
04:55
General news
Existing Home Sales to be reported at 10:00 »

October Existing Home…

GROW

U.S. Global Investors

$2.87

0.32 (12.55%)

, AG

First Majestic

$6.66

-0.13 (-1.91%)

04:55
11/21/17
11/21
04:55
11/21/17
04:55
Conference/Events
Cambridge House International to hold a summit »

Silver and Gold Summit…

GROW

U.S. Global Investors

$2.87

0.32 (12.55%)

AG

First Majestic

$6.66

-0.13 (-1.91%)

MUX

McEwen Mining

$1.99

-0.04 (-1.97%)

MAG

MAG Silver

$10.98

-0.07 (-0.63%)

CORVF

Corvus Gold

$1.07

0.0203 (1.93%)

FSM

Fortuna Silver Mines

$4.34

0.07 (1.64%)

UEC

Uranium Energy

$1.44

-0.05 (-3.36%)

WPM

Wheaton Precious Metals

$20.47

-0.45 (-2.15%)

SMTS

Sierra Metals

$2.39

-0.0099 (-0.41%)

SPG

Simon Property

$159.01

-2.94 (-1.82%)

EXK

Endeavour Silver

$2.07

-0.07 (-3.27%)

HL

Hecla Mining

$3.85

-0.0275 (-0.71%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

FSNUY

Fresenius SE

$18.48

-0.27 (-1.44%)

04:55
11/21/17
11/21
04:55
11/21/17
04:55
Conference/Events
Fresenius SE has a conference call hosted by JPMorgan »

JPMorgan Analyst…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

DPLO

Diplomat Pharmacy

$15.94

0.94 (6.27%)

04:55
11/21/17
11/21
04:55
11/21/17
04:55
Conference/Events
Diplomat Pharmacy management to meet with Needham »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

  • 22

    Nov

  • 29

    Nov

ATUS

Altice USA

$20.48

0.62 (3.12%)

04:55
11/21/17
11/21
04:55
11/21/17
04:55
Conference/Events
Morgan Stanley European telecom analysts hold analyst/industry conference call »

European Analysts discuss…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

PCYG

Park City Group

$11.20

0.6 (5.66%)

04:55
11/21/17
11/21
04:55
11/21/17
04:55
Conference/Events
Park City Group management to meet with Loop Capital »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.